Related references
Note: Only part of the references are listed.Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities
Yoon-Jung Kang et al.
CANCER EPIDEMIOLOGY (2015)
Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells
Lina Yang et al.
CANCER LETTERS (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool
Manuel Stemmer et al.
PLOS ONE (2015)
Elimination of nonspecific bands in non-radioactive electrophoretic mobility shift assays using the digoxigenin system
Saimi Tokunaga et al.
ANALYTICAL BIOCHEMISTRY (2014)
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
Domenica Lorusso et al.
GYNECOLOGIC ONCOLOGY (2014)
c-Rel Downregulation Affects Cell Cycle Progression of Human Keratinocytes
Verena N. Lorenz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Three-dimensional printing of Hela cells for cervical tumor model in vitro
Yu Zhao et al.
BIOFABRICATION (2014)
Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system
Tetsushi Sakuma et al.
SCIENTIFIC REPORTS (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
F. Ann Ran et al.
CELL (2013)
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
Laura Soucek et al.
GENES & DEVELOPMENT (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition
R. Vidya Priyadarsini et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes
Beate Neumann et al.
NATURE (2010)
CRISPR/Cas, the Immune System of Bacteria and Archaea
Philippe Horvath et al.
SCIENCE (2010)
Identification of new Rel/NFκB regulatory networks by focused genome location analysis
Adriana De Siervi et al.
CELL CYCLE (2009)
RNAi-Mediated c-Rel Silencing Leads to Apoptosis of B Cell Tumor Cells and Suppresses Antigenic Immune Response In Vivo
Wenzhi Tian et al.
PLOS ONE (2009)
NF-κB in the Nervous System
Barbara Kaltschmidt et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
IKK-i/IKKε controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation
Mazhar Adli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKKε
Jennifer Harris et al.
JOURNAL OF IMMUNOLOGY (2006)
Good cop, bad cop:: the different faces of NF-κB
ND Perkins et al.
CELL DEATH AND DIFFERENTIATION (2006)
Inducible IκB kinase/IκB kinase ε expression is induced by CK2 and promotes aberrant nuclear factor-κB activation in breast cancer cells
SF Eddy et al.
CANCER RESEARCH (2005)
Apoptosis effects of Xrel3 c-Rel/nuclear factor-kappa B homolog in human cervical cancer cells
M Shehata et al.
CELL BIOLOGY INTERNATIONAL (2005)
Inflammation-associated cancer:: NF-κB is the lynchpin
QT Li et al.
TRENDS IN IMMUNOLOGY (2005)
Role of ICAM1 in invasion of human breast cancer cells
C Rosette et al.
CARCINOGENESIS (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells
Marlene F. Shehata
CANCER CELL INTERNATIONAL (2005)
The c-Rel transcription factor and B-cell proliferation: a deal with the devil
TD Gilmore et al.
ONCOGENE (2004)
Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas
J Houldsworth et al.
BLOOD (2004)
Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription
H Buss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-κB-dependent c-myc expression
R Grumont et al.
IMMUNITY (2004)
Dual apoptotic effect of Xrel3 c-Rel/NF-kappa B homolog in human cervical cancer cells
M Shehata et al.
CELL BIOLOGY INTERNATIONAL (2004)
NF-κB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix
A Nair et al.
ONCOGENE (2003)
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
GJ Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Human papillomavirus update with a particular focus on cervical disease
SM Garland
PATHOLOGY (2002)
Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel
TD Gilmore et al.
ONCOGENE (2001)
TGF-β1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2)
F Strutz et al.
KIDNEY INTERNATIONAL (2001)
The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression
M Grossmann et al.
EMBO JOURNAL (2000)
The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-xL
CL Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)